HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luc Mouthon Selected Research

Microscopic Polyangiitis

1/2022Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2020Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry.
1/2020Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.
1/2018Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).
1/2018Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
11/2017Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors: A Randomized, Controlled Trial.
3/2016Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
3/2016Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients.
4/2015Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
11/2014Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luc Mouthon Research Topics

Disease

52Systemic Scleroderma (Systemic Sclerosis)
04/2024 - 05/2002
52Vasculitis (Vasculitides)
11/2022 - 11/2003
29Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
11/2023 - 11/2003
26Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2023 - 08/2007
24Infections
11/2023 - 12/2002
23Microscopic Polyangiitis
01/2022 - 02/2003
19Autoimmune Diseases (Autoimmune Disease)
01/2024 - 01/2002
17Churg-Strauss Syndrome (Allergic Angiitis)
01/2021 - 11/2003
14Interstitial Lung Diseases (Interstitial Lung Disease)
01/2024 - 12/2006
14Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 12/2003
13Inflammation (Inflammations)
01/2022 - 11/2005
12Polyarteritis Nodosa (Periarteritis Nodosa)
01/2022 - 02/2003
10COVID-19
02/2024 - 01/2020
10Giant Cell Arteritis (Horton Disease)
03/2021 - 10/2008
10Systemic Vasculitis
12/2020 - 03/2005
8Pulmonary Arterial Hypertension
10/2020 - 05/2008
7Diffuse Scleroderma (Progressive Systemic Sclerosis)
10/2023 - 06/2004
7Renal Insufficiency (Renal Failure)
01/2023 - 05/2006
7Neoplasms (Cancer)
10/2022 - 04/2004
7Fibrosis (Cirrhosis)
04/2022 - 05/2007
7Asthma (Bronchial Asthma)
01/2021 - 10/2004
6Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2023 - 01/2005
6Glomerulonephritis
01/2023 - 05/2007
6Thrombosis (Thrombus)
12/2022 - 01/2005
6Connective Tissue Diseases (Connective Tissue Disease)
09/2018 - 06/2005
6Rheumatoid Arthritis
01/2013 - 02/2007
5Arthritis (Polyarthritis)
10/2023 - 12/2006
5Thrombotic Microangiopathies
10/2023 - 01/2011
5Cardiomyopathies (Cardiomyopathy)
01/2023 - 02/2013
5Hemorrhage
12/2022 - 02/2014
5Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 11/2005
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018 - 09/2007
5Necrosis
04/2014 - 11/2005
4Arthralgia (Joint Pain)
01/2022 - 12/2007
4Ischemia
09/2021 - 04/2006
4digital ulcers
10/2020 - 04/2006
4Mononeuropathies (Mononeuritis Multiplex)
10/2020 - 02/2014
4Lymphopenia (Lymphocytopenia)
05/2017 - 05/2006
4Familial Primary Pulmonary Hypertension
06/2012 - 06/2002
3Immune System Diseases (Immune Disorders)
01/2023 - 12/2003
3Pneumonia (Pneumonitis)
10/2022 - 05/2020
3Hepatitis B
12/2020 - 03/2008
3Paraproteinemias (Monoclonal Gammopathy)
09/2020 - 08/2002
3IgA Vasculitis (Purpura, Schoenlein Henoch)
09/2020 - 03/2008
3Body Weight (Weight, Body)
04/2020 - 12/2008
3Rare Diseases (Rare Disease)
01/2020 - 12/2006
3Muscular Diseases (Myopathy)
01/2020 - 05/2006
3Ulcer
09/2018 - 02/2008
3Fever (Fevers)
07/2017 - 11/2005
3Human Influenza (Influenza)
01/2017 - 09/2009
3Pure Red-Cell Aplasia
02/2015 - 06/2005
3Vascular Remodeling
11/2014 - 06/2009
3Eosinophilia
02/2014 - 10/2004
3Opportunistic Infections (Opportunistic Infection)
09/2010 - 02/2009
3Virus Diseases (Viral Diseases)
03/2008 - 02/2003
2Mixed Connective Tissue Disease (MCTD)
04/2024 - 10/2023

Drug/Important Bio-Agent (IBA)

53AntibodiesIBA
04/2024 - 08/2002
41Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2023 - 10/2004
25Rituximab (Mabthera)FDA Link
11/2023 - 05/2006
20Adrenal Cortex Hormones (Corticosteroids)IBA
10/2020 - 02/2003
19AutoantibodiesIBA
04/2022 - 01/2002
17Immunosuppressive Agents (Immunosuppressants)IBA
01/2024 - 06/2005
16Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2022 - 06/2002
16Immunoglobulin G (IgG)IBA
01/2018 - 01/2002
15Intravenous Immunoglobulins (IVIG)FDA Link
01/2020 - 01/2002
15AntigensIBA
02/2017 - 11/2003
13GlucocorticoidsIBA
10/2022 - 02/2003
10Proteins (Proteins, Gene)FDA Link
01/2023 - 04/2007
10Myeloblastin (Proteinase 3)IBA
01/2019 - 05/2007
9CytokinesIBA
11/2023 - 01/2002
7Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2016
7ametantrone (HAQ)IBA
01/2019 - 02/2007
7Azathioprine (Imuran)FDA LinkGeneric
01/2018 - 06/2008
6Complement System Proteins (Complement)IBA
10/2023 - 01/2002
6Peroxidase (Myeloperoxidase)IBA
01/2022 - 10/2004
5CreatinineIBA
01/2023 - 05/2007
5VaccinesIBA
12/2022 - 09/2009
4Monoclonal AntibodiesIBA
12/2022 - 02/2007
4Prednisone (Sone)FDA LinkGeneric
11/2022 - 10/2004
4Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 12/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 10/2004
4Immunoglobulins (Immunoglobulin)IBA
01/2020 - 08/2002
4SteroidsIBA
01/2018 - 12/2007
4Immunoglobulin M (IgM)IBA
01/2012 - 11/2003
4Epoprostenol (Prostacyclin)FDA LinkGeneric
02/2008 - 06/2002
4CollagenIBA
12/2006 - 05/2002
3Antiphospholipid AntibodiesIBA
12/2022 - 12/2016
3RNA (Ribonucleic Acid)IBA
01/2022 - 07/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 08/2013
3RNA Polymerase IIIIBA
09/2017 - 08/2007
3anti-endothelial cell antibodyIBA
02/2017 - 10/2008
3AutoantigensIBA
09/2012 - 08/2007
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2006 - 06/2002

Therapy/Procedure

47Therapeutics
03/2024 - 06/2002
7Plasma Exchange
12/2022 - 05/2006
5Remission Induction
01/2023 - 05/2014
4Transplantation
10/2014 - 01/2003
3Aftercare (After-Treatment)
01/2023 - 09/2005
3Surgical Amputation (Amputations)
10/2020 - 04/2014
3Physical Therapy Modalities (Physical Therapy Technique)
01/2019 - 12/2013